BACKGROUND Women with congenital heart disease (CHD) may be at increased risk for adverse events during pregnancy and delivery.
L abor, delivery, and the postpartum period are a time of increased arrhythmia and heart failure incidences, even in patients without cardiovascular disease. Possible explanations include altered hemodynamics with myocardial irritability owing to increases in intravascular volume, hypokalemia, autonomic changes, and hormonal influences on adrenergic receptor number and behavior. [1] [2] [3] Maternal arrhythmias increase during labor and delivery, possibly owing to volume shifts and hypertension. 4 In women with arrhythmias before pregnancy, recurrence during pregnancy is common and is associated with an increased risk for fetal complications. 5 Despite these risks, a small series including women with implantable cardioverter defibrillators followed up during subsequent pregnancies has revealed no increase in implantable cardioverter defibrillator shocks. 6, 7 Likewise, congestive heart failure (CHF) is more common during and after pregnancy in women without a history of cardiovascular disease. 8 Owing to improvements in the treatment of congenital heart disease (CHD), most patients with CHD now survive to adulthood, and more than 1 million adults are living with CHD in the United States. 9, 10 As patients with CHD live longer, arrhythmias are an increasing cause of morbidity and mortality. 11, 12 In addition, more women with CHD are becoming pregnant, and these patients are at increased risk for arrhythmias and CHF. 13, 14 We sought to evaluate contemporary maternal and fetal outcomes in women with and without CHD during admissions for delivery in California. We used the Health Care Cost and Utilization Project (HCUP), a group of databases that have already been used to study CHD hospitalizations and procedures, [15] [16] [17] [18] [19] to evaluate cardiac and other complications of labor and delivery for women with and without CHD from 2005 through 2011.
Methods
Admissions for female patients with a diagnosis code from the International Classification of Diseases, Ninth Revision (ICD-9), a procedure code from the International Classification of Diseases, Ninth Revision, Clinical Modification, or a diagnosis related group code for delivery 20,21 from January 1, 2005, through December 31, 2011, were identified from HCUP's California State Inpatient Database. If an ICD-9 code for cesarean delivery was not present and the delivery type was not specified, delivery was categorized as vaginal. The details of the ICD-9 codes used are listed in eTable 1 in the Supplement. Identifying patient information was anonymized before analysis, and certification to use these deidentified HCUP data was obtained from the Committee on Human Research at the University of California, San Francisco. Diagnoses of CHD were determined by ICD-9 or Current Procedural Terminology codes used by others previously (eTable 2 in the Supplement).
17,22-24 If a CHD diagnosis code was present for any encounter during the study period, the patient was assigned that diagnosis for all visits. Complex CHD included endocardial cushion defects, hypoplastic left heart syndrome, tetralogy of Fallot, transposition of the great arteries, truncus arteriousus, and univentricular heart defects. All other CHD defects were classified as noncomplex. [22] [23] [24] Patients with complex and noncomplex CHD diagnoses were assigned to the complex CHD group. Maternal cardiovascular outcomes included in-hospital atrial arrhythmias (including atrial fibrillation, atrial flutter, or paroxysmal supraventricular tachycardia), serious ventricular arrhythmias (including paroxysmal ventricular tachycardia, ventricular fibrillation, ventricular flutter, cardiac arrest, and sudden death due to an unknown cause during the puerperium), eclampsia or preeclampsia, and CHF (eTable 3 in the Supplement). Other maternal outcomes included length of stay and in-hospital mortality. Maternal and fetal outcomes, defined by others previously, 25 included preterm labor, anemia complicating pregnancy, placental abnormalities (previa, abruptio, or accreta), infection during labor, fetal growth restriction, fetal distress, and fetal death. Outcomes after discharge included readmission to the hospital (after excluding admissions for subsequent delivery) for CHF, atrial arrhythmias, and serious ventricular arrhythmias at 1 year. Women with a primary residence outside California were excluded from this analysis. Because these outcomes were uncommon and because we found no significant differences between the complex and noncomplex CHD groups, both were analyzed as a single group for the 1-year follow-up.
Medical comorbidities were classified based on ICD-9 diagnosis codes for coronary artery disease, CHF, cerebrovascular disease, chronic kidney disease, hypertension, diabetes, and depression (eTable 4 in the Supplement).
19,25 Patients were identified as having the comorbidity of interest if the diagnosis code was recorded for any health care encounter from January 1, 2005, to the admission date for delivery. Thus, these comorbidities included comorbidities diagnosed before pregnancy and those diagnosed during pregnancy but before the admission for delivery.
were not normally distributed are presented as median (interquartile range [IQR]). We compared outcomes using multivariate logistic regression with the following covariates: age, race, cesarean delivery, multiple birth, maternal history of CHF, hypertension, coronary artery disease, chronic kidney disease, diabetes, and cerebrovascular disease. We assessed the association of CHD with readmission to the hospital for reasons other than subsequent delivery by using survival analysis, with failure defined as readmission to the hospital to 7 years after delivery. Women without a readmission were administratively censored on December 31, 2011. The association of CHD with the hazard of readmission was evaluated with Cox proportional hazards modeling. Beginning with an a priori set of predictors, backward selection was used to remove covariates with P < .1 in adjusted analyses. Two-tailed P < .05 was considered to be statistically significant. Owing to HCUP publication requirements, 26 cell sizes of less than 10 are not reported, although the exact number is used in the analyses. Statistical analyses were performed using STATA/SE software (version 13.1; StataCorp).
Results
Of a total of 27 907 535 inpatient hospitalizations in California from January Median length of stay was longer for women with CHD compared with women without CHD (3 [IQR, 2-4] vs 2 [IQR, 2-3] days; P < .001). In addition, 29 women with complex CHD (11.1%) and 191 women with noncomplex CHD (6.0%) were admitted for longer than 7 days, compared with only 49 089 women without CHD (1.3%). After multivariate adjustment, CHD was associated with greater odds of admissions longer than 1 week ( Table 2) . Preeclampsia or eclampsia was observed in 19 women with complex CHD (7.3%), 182 women with noncomplex CHD (5.7%), and 122 539 women without CHD (3.4%). After multivariate adjustment, noncomplex CHD was significantly associated with increased odds of preeclampsia or eclampsia (OR, 1.3; 95% CI, 1.1-1.5; P = .003); the association for complex CHD was not significant (OR, 1.5; 95% CI, 0.9-2.4; P = .12). Incident CHF, atrial arrhythmias, serious ventricular arrhythmias, and maternal mortality were uncommon during hospitalization, each occurring in fewer than 0.5% of women with CHD (Table 2) . After multivariate adjustment, noncomplex CHD (OR, 9.7; 95% CI, 4.7-20.0; P < .001) and complex CHD (OR, 56.6; 95% CI, 17.6-182.5; P < .001) were associated with greater odds of CHF. Similar associations for noncomplex CHD (OR, 8.2; 95% CI, 3.0-22.7; P < .001) and complex CHD (OR, 31.8; 95% CI, 4.3-236.3; P = .001) were found for atrial arrhythmias. After multivariate adjustment, only complex CHD was associated with greater odds of serious ventricular arrhythmias (OR, 35.3; 95% CI, 13.4-93.5; P < .001) or maternal in-hospital mortality (OR, 79.1; 95% CI, 23.9-261.8; P < .001) ( Table 2) .
Fetal growth restriction was reported in 14 women with complex CHD (5.3%), 76 women with noncomplex CHD (2.4%), and 48 765 women without CHD (1.3%). After multivariate adjustment, noncomplex CHD (OR, 1.6; 95% CI, 1.3-2.0; P < .001) and complex CHD (OR, 3.5; 95% CI, 2.1-6.1; P < .001) were associated with greater odds of fetal growth restriction. Fetal death occurred in no deliveries for women with complex CHD, 22 deliveries for women with noncomplex CHD (0.7%), and 13 017 deliveries for women without CHD (0.4%). After multivariate adjustment, noncomplex CHD was associated with greater odds of fetal death compared with women without CHD (OR, 1.7; 95% CI, 1.1-2.6; P = .02).
Maternal Outcomes After Hospital Discharge
When women were followed up after discharge, 30 155 women without CHD (1.1%) and 166 women with CHD (5.6%) were readmitted to the hospital within 30 days (P < .001); the readmission rate exclusive of subsequent deliveries remained higher for women with CHD at 1 year (OR, 3.6; 95% CI, 3.3-4.0; P < .001) ( Table 3 ) and to 7 years after discharge (χ 2 =3941, P < .001, log-rank test for comparing complex CHD, noncomplex CHD, and no CHD) (Figure 1) . At 1 year, readmissions for CHF (OR, 6.7; 95% CI, 4.0-11.1; P < .001), atrial arrhythmias (OR, 10.9; 95% CI, 7.0-17.1; P < .001), and serious ventricular arrhythmias (OR, 6.2; 95% CI, 3.5-11.2; P < .001) were more common for women with CHD than for those without (Table 3 ). For readmissions within 1 year of delivery, the 10 most common diagnoses were noncardiac for women without CHD, whereas for women with CHD, 3 of the top 10 were cardiac (CHF, ostium secundum, atrial septal defect, and chest pain). After multivariate analysis, noncomplex CHD (hazard ratio, 3.88; 95% CI, 3.66-4.12) and complex CHD (hazard ratio, 4.51; 95% CI, 3.70-5.49) had the largest association with increasing the hazard of readmission ( Figure 2 ).
Discussion
In this study of more than 3.6 million admissions for delivery in California during a 7-year period that accounted for more than 98% of all live births, women with CHD were more likely to have a history of CHF, undergo cesarean delivery, and have Abbreviations: AF, atrial fibrillation; AFL, atrial flutter; AOR, adjusted odds ratio; CHD, congenital heart disease; CHF, congestive heart failure; IQR, interquartile range; LOS, length of stay; SCA, sudden cardiac arrest; SVT, supraventricular tachycardia; VF, ventricular fibrillation; VT, ventricular tachycardia.
a Calculated using multivariate logistic regression.
b Although Health Care Cost and Utilization Project policy prohibits reporting cell frequencies less than 10, actual numbers were known to investigators and used for analyses.
Maternal longer lengths of stay. Incident maternal CHF, arrhythmias, and mortality were uncommon for all groups of women, but the odds of these outcomes were substantially greater for women with complex CHD. The adjusted odds of CHF, atrial arrhythmias, and maternal death were also increased for women with noncomplex CHD. At 1 year, readmissions for CHF, atrial arrhythmias, and serious ventricular arrhythmias were more common for women with CHD. After multivariate analysis, CHD had a greater associaton with increasing the hazard of readmission than did diabetes, chronic kidney disease, or hypertension. Despite these associations, the absolute risks for adverse cardiovascular outcomes among women with CHD were still low. The risks for incident CHF, supraventricular arrhythmias, serious ventricular arrhythmias, and maternal inhospital mortality were less than 0.5% among women with CHD. The magnitude of the increases in relative risk among women with CHD appears to be high in part owing to comparisons against the rare levels of these complications in the general population. Women with CHD more often underwent cesarean delivery, but the underlying reasons for this difference are unclear. Cesarean delivery is more commonly used in mothers who have delivered by cesarean delivery previously and in cases of breech presentation, dystocia, and fetal distress. [28] [29] [30] Women with CHD were not more likely to have codes for fetal distress; therefore, increased use of cesarean delivery does not seem to be attributable to fetal instability. Cesarean deliveries may have been more likely to be planned owing to physician and/or patient preference because of the belief that the procedure has less effect on maternal physiology, although at present no definitive data on this issue exist. We found a higher rate of cesarean delivery among women with CHD (46.2% for complex CHD and 38.8% for noncomplex CHD) than did other studies. In a multicenter cohort of mothers with CHD from more than a decade ago, Siu and colleagues 31 found that 27% of births were by cesarean delivery and 96% of these were for obstetric indications (compared with maternal cardiac status indication in only 4%). We also found significantly greater odds of preeclampsia or eclampsia in women with noncomplex CHD and increased odds in women with complex CHD. Reduced placental perfusion may cause preeclampsia, 32 which could be more common in women with CHD. Studies have shown that compared with the general population and women with repaired defects, women with an unrepaired atrial septal defect or ventricular septal defect have an increased risk for preeclampsia. 33, 34 In addition, even in women with CHD, preeclampsia or eclampsia is uncommon and only occurred in 7.3% of women in our complex CHD group. Compared with the studies by Karamlou and colleagues 35 and Thompson and colleagues, 36 our study captured nearly every birth in California, as opposed to a representative sample of the United States obtained from the HCUP Nationwide Inpatient Sample. All 3 studies found higher rates of cesarean delivery and cardiac complications among women with CHD. Because of differences between the databases, the present study was also able to ascertain serious complications requiring readmission after discharge. Cardiac complications were less commonly observed in this study than in the study by Siu and colleagues, 31 who reported a primary cardiac event in 13% of completed pregnancies. However, more than half of these events occurred in the prepartum period, which was not evaluated in the present study. One review 13 found cardiac events in 1.9%, CHF in 4.8%, and arrhythmias in 4.5% of deliveries in women with CHD. A Dutch national study of CHD 37 identified cardiovascular events at 1 year in 6.4% of pregnancies, and 9 of 11 events were newonset arrhythmias. In our contemporary statewide study of nearly every delivery to mothers with CHD, arrhythmias occurred in approximately 1% of women. Includes admissions other than for subsequent delivery. P values comparing equality of survivor functions for complex, noncomplex, and no congenital heart disease (CHD) were calculated using log-rank test (χ 2 = 3941; P < .01). Abbreviations: AOR, adjusted odds ratio; CHD, congenital heart disease; CHF, congestive heart failure.
a Excludes admissions for subsequent delivery and women with a primary residence outside California.
b Noncomplex CHD and complex CHD were pooled owing to small numbers of outcomes and the fact that the 2 groups were not significantly different. Groups were compared with χ 2 tests, and all differences were statistically significant (P < .001).
Prior studies of women with CHD have found that their offspring are at increased risk for premature birth, being small for gestational age, and neonatal mortality. 13, 38, 39 We found greater odds of fetal growth restriction for women with CHD and greater odds of fetal death for women with noncomplex CHD. Patients with complex disease are at particular risk for intrauterine growth restriction, and monitoring for such complications requires vigilance by obstetricians. Owing to coding restrictions, we could not examine prematurity as an end point or as a mediator of the association between maternal CHD and neonatal mortality. Prior studies have also shown that miscarriages and terminations for medical reasons are more common in women with CHD, 13, 38 but this study did not capture any outcomes before the time of delivery. This study also found a higher risk for maternal readmission among mothers with CHD at 30 days and 1 and 7 years. Although we examined the cause of readmission at 1 year, we did not do so at 7 years, and the higher readmission rates across long-term follow-up may be attributable to the natural history of CHD and not to complications of pregnancy.
Limitations
Despite the large number of women with CHD captured in the study, this study has several limitations. First, ICD-9 codes have imperfect sensitivity and specificity, 40 and CHD may have been undercoded. However, undercoding is unlikely to bias the results, because even a small number of women with CHD misclassified as not having CHD would not have a sizable effect on summary estimates of more than 3.6 million women. Second, the administrative nature of the database does not allow the medical records of mothers and neonates to be linked to determine the longterm health outcomes of these infants. Third, this analysis captured only women who chose to become pregnant and carried pregnancies to term. We did not evaluate women who chose not to become pregnant or who did not carry pregnancies to term, which may account for approximately 20% of pregnancies among women with CHD. 13 Fourth, the number of women with CHD who delivered at low-volume centers was small, and multivariate analysis did not demonstrate an association of hospital delivery volume with outcomes for women with CHD. Fifth, the inpatient nature of this database did not allow us to capture intensity or quality of care before and after delivery. In a recent study of cardiovascular deaths related to pregnancy in California, health care professional factors were found to play a role in most cardiovascular deaths. 41 Finally, for the follow-up analysis, only women who were readmitted to a California hospital were captured; therefore, women who moved or died outside the hospital were not captured.
Conclusions
In this study of nearly all women admitted to California hospitals for delivery during a 7-year period, women with CHD Includes admissions other than for subsequent delivery. CHD indicates congenital heart disease; CHF, congestive heart failure; HR, hazard ratio; and NA, not applicable. were more likely to undergo cesarean delivery and have a longer length of stay. Incident maternal CHF, arrhythmias, and mortality were uncommon in all groups of women, but CHD was significantly associated with incident CHF, atrial arrhythmias, fetal growth restriction, and hospital readmission. Complex CHD was a significant predictor of ventricular arrhythmias and maternal in-hospital mortality. These results may guide monitoring decisions and risk assessment for pregnant women with CHD at the time of delivery. Given the higher rate of cardiac and obstetrical complications, pregnant women with CHD should be treated in a center with expertise in adult CHD. In the past 30 years, the number of patients with adult congenital heart disease (ACHD) has progressively exceeded the number of children with CHD. 1 At present, more than 1.4 million individuals in the United States are living with ACHD. Many are women of childbearing age. Patients with ACHD are surviving to old age as the result of better surgical techniques and medical management. Care in specialized ACHD centers has been demonstrated to reduce mortality among these patients. 2 They often have reasonably good functional capacity and hope to participate in the activities of their similarly aged peers, including childbearing. In developed countries, most pregnant women with heart disease now have CHD, which represents a shift in the most common cardiac diseases seen in pregnancy from valvular heart disease to CHD. This shift leaves the obstetric team and its consultants with a more diverse and complex set of clinical problems to address in pregnant patients compared with the earlier era of rheumatic heart disease. This recognition has led to reports of outcomes of pregnancy in patients with specific congenital lesions such as atrial septal defect or tetralogy of Fallot.
Beginning with the landmark prospective CARPREG (Cardiac Disease in Pregnancy) trial by Siu and colleagues, 3 relative risk stratification studies have identified maternal cardiac factors indicative of the degree of risk for an adverse maternal or fetal outcome of a pregnancy. In the large retrospective ZAHARA (Zwangerschap bij Aangeboren Hartafwijkingen) study, 4 retrospectively analyze outcomes of more than 3.4 million pregnancies in California during a 7-year span by using an insurance database approach. More than 98% of pregnancies in California during the study period were captured using this approach, including more than 3400 women with ACHD. Based on the anatomical diagnoses taken from International Classification of Diseases, Ninth Revision codes, patients with ACHD were divided into noncomplex and complex categories, including 262 patients with complex CHD. Each category contains a wide spectrum of anatomical and hemodynamic complexity. Risk stratification using CARPREG or ZAHARA criteria was not feasible. However, Hayward and colleagues 5 offer a look into the outcomes of a population of patients with ACHD without the referral bias attendant on being seen in an ACHD center. For the first time, a more accurate measure of absolute risk is available. To no surprise, the relative risk of heart failure, atrial or ventricular arrhythmias, or sudden death is increased significantly in the population with ACHD, particularly in those with complex disease. This increase is concordant with the findings of others. 3, 4 However, the good news is that the absolute risk remains fairly low, especially for the much more numerous patients with noncomplex CHD. In particular, the relative risk for ventricular arrhythmias or sudden cardiac arrest was only significantly elevated in the group with complex disease but was still quite rare. Most women with ACHD, therefore, can reasonably expect a good chance of an uncomplicated pregnancy, despite an increased relative risk for an adverse event. This counterbalances alarming patients and physicians with isolated high rates of relative risk. Nonetheless, the pregnant population with ACHD experiences significantly higher rates of cardiovascular complications and readmission than pregnant patients without ACHD. Hayward and colleagues 5 do not track antepartum complications or rates of miscarriage or termination. How many patients were unnecessarily advised to avoid pregnancy? How many patients were unnecessarily advised to have a safe pregnancy terminated? How many patients had never had a conversation with their cardiologists concerning the advisability and the timing of pregnancy or how to avoid one? To secure Abbreviation: CHD, congenital heart disease.
a Some patients have multiple CHD defects classified. Health Care Cost and Utilization Project policy prohibits reporting cell frequencies of less than 10.
